NASDAQ:TKAI
Delisted

Tokai Pharmaceuticals Fund Signals

$0.610
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 41 days ( 88.88 % )
Last Price $0.610 0 %
High/ Low $0.610 - $0.610 0%
Chg 7 Days N/A $0.610 $0.610
Chg 30 Days N/A $0.610 $0.610
Chg 12 mos -41.90 % $1.05 $0.610
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -6.32 % Width: 1,170.90 %
Pred. range - 3 mos $0.610 - $0.610 0 % - 0 %
Pred. range - 12 mos $0.396 - $5.03 -35.15 % - 724.14 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Buy Jan 08, 2018 - 7 days
Short/Long MA avg 3 mos Buy Jan 08, 2018 - 7 days
Short MA avg 12 mos Sell May 12, 2017 - 41 days
Long MA avg 12 mos Sell May 12, 2017 - 41 days
Short/Long MA avg 12 mos Sell Dec 01, 2017 - 30 days
Pivot Short Buy Jan 15, 2018 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Tokai Pharmaceuticals

Tokai Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. Its lead drug candidate is galeterone, an oral small molecule that is in various clinical trials for the treatment of patients with metastatic castration-resistant prostate cancer. The company’s androgen receptor degradation (ARDA) drug discovery program is focused on identifying ... TKAI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT